Innoviva (INVA) Current Taxes (2022 - 2025)

Innoviva's (INVA) quarterly Current Taxes came in at $274000.0 in Q4 2025, down 82.23% on a QoQ basis from $1.5 million in Q1 2025.

Analysis

Innoviva (INVA) Current Taxes (2022 - 2025) Analysis & Trends

Innoviva (INVA) has 4 years of Current Taxes data on file, last reported at $274000.0 in Q4 2025.

Quarterly Current Taxes changed N/A year-over-year to $274000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $274000.0 (changed N/A YoY) and the FY2025 annual result came in at $274000.0, changed N/A from the prior year.
Current Taxes declined to $274000.0 in Q4 2025, from $1.5 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $33.8 million in Q3 2022 to a low of $154000.0 in Q4 2022.
A 4-year average of $4.9 million and a median of $214000.0 in 2022 frame the typical range for Current Taxes.
Annual changes were most pronounced in 2023 — Current Taxes plunged 99.54% — and 2024, when it soared 1603.25%.
Tracing INVA's Current Taxes over 4 years: stood at $154000.0 in 2022, then changed by 0.0% to $154000.0 in 2023, then soared by 1603.25% to $2.6 million in 2024, then sank by 89.55% to $274000.0 in 2025.
The last three Current Taxes figures came in at $274000.0 (Q4 2025), $1.5 million (Q1 2025), and $2.6 million (Q3 2024), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	76.32 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Innoviva	1.56 Bn	984.81 Mn	90.62 Mn	-

Historic Data

Download Data